3rd Dr. M. Gourie-Devi Oration successfully held today at NIMHANS, Bengaluru
Prof. Ammar Al-Chalabi (King’s College London, UK) delivered “The Mystery of ALS: Can It Be Solved?”
Insightful discussions on ALS & neuroscience research
#NIMHANS#ALSResearch#Neuroscience
I very much enjoyed my time at @NIMHANS_BLR. The clinical care for people with #ALS#MND is outstanding and the research is fascinating and world class. Thank you for inviting me to give this oration and for your wonderful hospitality.
🧠💤 Have MND/ALS? Help us understand.
Sleep is more than a symptom, it reflects underlying disease processes, affects quality of life, and may offer clues for new treatments.
Take part in a 15-min @kingsmnd survey to guide future care and research.
🔗 https://t.co/AfPcTlsjNV
We’re recruiting a PhD student at King’s College London @KingsIoPPN to use AI and big data (@uk_biobank) to uncover sex-specific molecular subtypes of Alzheimer’s and translate them into drug repurposing opportunities.
https://t.co/6h5KGerJAs
Wishing the best of luck to Kevin Sinfield CBE and his team as they kick off their 7 in 7: Together challenge today! 🏃 🏉
➡️ Join us in Dundee this Saturday: https://t.co/Tg0iCRPv7B
Kev spoke to @BBCBreakfast ahead of the start of his sixth #7in7 challenge to raise money for the fight against motor neurone disease. 🧡
#MND#7in7Together
London is calling 🇬🇧
Fully funded DRIVE-Health PhD positions at @KingsCollegeLon College London (@KingsIoPPN)
Join our Drug Discovery & Clinical Trials Optimisation Lab to work at the cutting edge of genomics, AI and neurodegeneration. https://t.co/iqCYOtDzqc
🌡️ Summer 2025 was the warmest on record in the UK, with four major heatwaves.
Extreme heat is no longer rare, and for people with MND ALS, it can be especially challenging.
We’re studying how people with MND prepare for and cope with heatwaves to guide future support 👇
Amyotrophic lateral sclerosis ALS/MND still has only one widely used treatment, and not everyone benefits in the same way. We wanted to understand why
No large-scale study had yet explored whether genetic variation in drug metabolism could shape ALS risk or treatment response
PhD Opportunity 🔉🔊
Interested in mixing epigenetics + AI to transform clinical trials? Join us (with David Watson & Sarah Marzi) to explore DNA methylation as a tool to personalise neurodegeneration trials. 🧬🖥️
Think big data &machine learning applied where it really matters
🚨 Join us for the next DEMON Network Drug Discovery & Clinical Trials seminar!
🗓 Thu 25 Sept, 3:30pm 🇬🇧
🎤 Prof Karyn Frick (Univ. of Wisconsin–Milwaukee)
🧠 Estrogens & memory: Translating basic research into therapies for menopause & Alzheimer’s disease
Data, data, data. The more data researchers have the better the insights they can get.
Sleep, as anyone with #mnd will know, becomes less relaxing & more a day to day focus on getting good sleep,
Please fill this survey in if you can #als#mnd patients
#united2endmnd
🧠💤 Have MND/ALS? We need your voice.
Sleep is more than a symptom, it reflects underlying disease processes, affects quality of life, and may offer clues for new treatments.
Take part in a 15-min @kingsmnd survey to guide future care and research.
🔗 https://t.co/8y9LT8wixv
The King’s MND Care & Research Team has been awarded the @KingsCollegeLon@KingsIoPPN Award for Collaborative Research Excellence. This recognises our shared mission to deliver integrated care and advance research in #MND and #ALS.
@AmmarAlChalabi